Orange, CA19 Active Studies

Ankylosing Spondylitis Clinical Trials in Orange, CA

Find 19 actively recruiting ankylosing spondylitis clinical trials in Orange, CA. Connect with local research sites and explore new treatment options.

19
Active Trials
16
Sponsors
36,766
Enrolling

Recruiting Ankylosing Spondylitis Studies in Orange

About Ankylosing Spondylitis Clinical Trials in Orange

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 19 ankylosing spondylitis clinical trials recruiting participants in Orange, CA. These studies are seeking a combined 36,766 participants. Research is being sponsored by Arbor Research Collaborative for Health, Genzyme, a Sanofi Company, Alliance for Clinical Trials in Oncology and 13 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Orange — FAQ

Are there ankylosing spondylitis clinical trials in Orange?

Yes, there are 19 ankylosing spondylitis clinical trials currently recruiting in Orange, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Orange?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Orange research site will contact you about next steps.

Are clinical trials in Orange free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Orange studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 19 active trials in Orange are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated October 12, 2026 from ClinicalTrials.gov